MatthewChristopherSomervilleMD

PubMed

• 14 citations
  Burden of Illness in Prostate Cancer Patients with a Low-to-Moderate Risk of Progression: A One-Year, Pan-European Observational Study
  Cesare Selli, Anders Bjartell, Javier Pérez Burgos, Matthew C. Somerville, Juan-Manuel Palacios, L Benjamin, Libby Black, Ramiro Castro> ;Prostate Cancer. 2014 Mar 13
• 6 citations
  Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prosta...
  M. Scott Lucia, David G. Bostwick, Matthew C. Somerville, Ivy L. Fowler, Roger S. Rittmaster> ;Archives of Pathology & Laboratory Medicine. 2013 Nov 27
• 8 citations
  The REDUCE Follow-Up Study: Low Rate of New Prostate Cancer Diagnoses Observed During a 2-Year, Observational, Followup Study of Men Who Participated in the REDUCE Trial
  Robert L. Grubb, Gerald L. Andriole, Matthew C. Somerville, Chrysa Mahoney, Michael J. Manyak, Ramiro Castro> ;The Journal of Urology. 2013 Mar 1
• 41 citations
  Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study
  Michael Marberger, Stephen J. Freedland, Gerald L. Andriole, Mark Emberton, Curtis A. Pettaway, Francesco Montorsi, Claudio Teloken, Roger S. Rittmaster, Matthew C. So...> ;BJU International. 2012 Apr 1
• 12 citations
  Biopsy Misidentification Identified by DNA Profiling in a Large Multicenter Trial
  Michael Marberger, John D. McConnell, Ivy L. Fowler, Gerald L. Andriole, David G. Bostwick, Matthew C. Somerville, Roger S. Rittmaster> ;Journal of Clinical Oncology. 2011 May 1
• 62 citations
  The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous...
  Gerald L. Andriole, David Bostwick, Otis W. Brawley, Leonard G. Gomella, Michael Marberger, Francesco Montorsi, Curtis A. Pettaway, Teuvo L.J. Tammela, Claudio Teloken...> ;The Journal of Urology. 2011 Jan 1
• 755 citations
  Effect of dutasteride on the risk of prostate cancer.
  Gerald L. Andriole, David G. Bostwick, Otis W. Brawley, Leonard G. Gomella, Michael Marberger, Francesco Montorsi, Curtis A. Pettaway, Teuvo L.J. Tammela, Claudio Telo...> ;The New England Journal of Medicine. 2010 Apr 8
• 296 citations
  The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial
  J. Curtis Nickel, Claus G. Roehrborn, Michael P. O'Leary, David G. Bostwick, Matthew C. Somerville, Roger S. Rittmaster> ;European Urology. 2007 Nov 20
• 54 citations
  Delay in the progression of low-risk prostate cancer: Rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDE...
  Neil Fleshner, Leonard G. Gomella, Michael S. Cookson, Antonio Finelli, Andrew Evans, Samir S. Taneja, M. Scott Lucia, Eric T. Wolford, Matthew C. Somerville, Roger S....> ;Contemporary Clinical Trials. 2007 Nov 1
• 77 citations
  Examination of the Relationship Between Symptoms of Prostatitis and Histological Inflammation: Baseline Data From the REDUCE Chemoprevention Trial
  J. Curtis Nickel, Claus G. Roehrborn, Michael P. O'Leary, David G. Bostwick, Matthew C. Somerville, Roger S. Rittmaster> ;The Journal of Urology. 2007 Sep 1
• 54 citations
  The dual 5-alpha-reductase inhibitor dutasteride induces atrophic changes and decreases relative cancer volume in human prostate.
  Jingxin Qiu, Junqi Qian, Matthew C. Somerville, Roger S. Rittmaster, Gerald L. Andriole, David G. Bostwick> ;Urology. 2005 Jan 1
• Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.
  Andriole, G., Bostwick, D., Brawley, O., Gomella, L., Marberger, M., Tindall, D., Breed, S., Somerville, M., Rittmaster, R.> ;J Urol. 2004 Oct
• Join now to see all